F110 AUGMENTOR NOZZLE SE, NSN: 2840-01-616-1301PR, PN: 9539M85G12

The contract solicits the supply of 85 F110 Augmentor Nozzle Sections, identified by NSN 2840-01-616-1301PR and part number 9539M85G12, under a firm fixed price arrangement through a Basic Ordering Agreement. Deliveries are structured in two contract line items: 48 units due by August 28, 2026, and 37 units due by January 18, 2027, with the work to be performed at General Electric Company’s facility in Cincinnati, Ohio. The government will inspect and accept the items at the contractor’s origin under F.O.B. Origin terms as defined by FAR 52.247-29, with final delivery destined to DoDAAC DGR002 at Tinker AFB, Oklahoma. All items must comply strictly with military packaging standards MIL-STD-2073-1 Revision E and marking standards MIL-STD-129 Revision R, including preservation level MIL B, packaging level AAA, and specific cushioning and wrap materials. Unique identification marking per MIL-STD-130 is mandatory, with the CAGE code 07482 and part number embedded in durable, machine-readable formats. Wood packaging must conform to ISPM No. 15, requiring debarking and heat treatment certified by an ALSC-recognized agency. Compliance with DFARS 252.211.7003 for IUID is required, and all submissions must include documentation per AFMC Form 158 and DD Form 1653. Pricing is structured with two quantity ranges—1 to 42 units and 43 to 85 units—but unit and extended prices remain unfilled, indicating proposal submission is required to finalize cost. The solicitation is open to all offerors without set-aside classification, and proposals must be submitted electronically by December 1, 2025, at 3:00 PM CST via Sam.gov. Contract administration is managed by the Department of Defense’s DLA Weapons Support at Tinker AFB, with Asaycia Clayton as the primary point of contact and other personnel including Chiquita Cole and Richard Davis involved in oversight and packaging validation. Evaluation will assess technical compliance with packaging, marking, IUID, and wood treatment standards alongside pricing, implying a trade-off approach rather than LPT